Towards Healthcare
DNA Synthesis Market to Grow at 17.42% CAGR till 2034

DNA Synthesis Market Trends Indicate Strong Demand in Future Applications

Projections indicate that, the global DNA synthesis market will increase from USD 4.62 billion in 2024 to USD 23.1 billion by 2034, experiencing a CAGR of 17.42% over the next 10 years. The DNA synthesis market is rising due to the rise in gene therapies for the treatment of cancer, rare diseases, and other chronic conditions. North America leads the market due to the presence of major market players.

Content

  • Insight Code: 6162
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The DNA synthesis market is worth USD 5.43 billion in 2025, and by 2034, it is forecasted to hit USD 23.1 billion, registering a CAGR of 17.42% over the decade.

North America is currently leading the DNA synthesis market share 41% due to rising cancer cases and other chronic conditions.

The DNA synthesis market includes five segments such as by product type, by technology, by application, by end-user, and by region.

Some key players include Thermo Fisher Scientific, Twist Biosciences, GenScript Biotech, Agilent Technologies, etc.

Genetics is used in medicine to diagnose hereditary illnesses, forecast disease risk, customise care, and provide new treatments like pharmacogenetics and gene therapy.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions